Loading...
Please wait, while we are loading the content...
Mutation-specific therapies that potentiate cystic fibrosis transmembrane conductance regulator (CFTR) function in cystic fibrosis
| Content Provider | Scilit |
|---|---|
| Author | Sinha, Ian P. Southern, Kevin W. Dwan, Kerry Echevarria, Carlos Schechter, Michael |
| Copyright Year | 2012 |
| Related Links | https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009841/pdf/full |
| DOI | 10.1002/14651858.cd009841 |
| Issue Number | 5 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2012-05-16 |
| Access Restriction | Open |
| Subject Keyword | Aminophenols [*therapeutic Use] Phase Ii As Topic Phase Iii As Topic Cystic Fibrosis [*drug Therapy Cystic Fibrosis Transmembrane Conductance Regulator [drug Effects Forced Expiratory Volume [drug Effects] Molecular Targeted Therapy [methods] Mucociliary Clearance Quinolones [*therapeutic Use] Randomized Controlled Trials As Topic |
| Content Type | Text |